Tesla stock slipped on Tuesday after Bank of America said it sees shares fairly priced, with some risk to the downside.

Tesla shares dropped Tuesday as federal regulators said they’re looking into crashes related to the company's automated vehicle summoning features and analysts at Bank of America downgraded the stock.

Exclusive: Mike Tully’s wife ‘threatened him with divorce’ if he relocated for work, according to a previously unreported federal lawsuit obtained by The Independent

It's been another week, and Bank of America analysts are mixed on Tesla (TSLA) following a major development with a novel technology. The same BofA analysts delivered new insights following CES, and Citibank analysts gave some positive insight about Stellantis.

Come on now. Tesla deserves a bull rating. It always has deserved a bull rating. A Bull-S rating.Tesla and Musk both deserve Bull-S ratings. And no, "S" does not mean Sell! Although if you own it you should sell it.

Tesla (TSLA) shares are under pressure after Bank of America analysts downgraded the stock to Neutral from Buy, citing valuation concerns. Despite the downgrade, analysts lifted their price target to $490 from $400.

Tesla Inc.’s stock slipped 0.9% Tuesday, after Bank of America downgraded the stock to neutral from buy, arguing that it already reflects the long-term potential of such items as robotaxi and energy storage,

Tesla (TSLA) stock headed higher on Wednesday ... was an "admission" that the SEC could not bring an "actual case". Bank of America (BAC) was the latest big bank to report results on Thursday ...

Tesla (TSLA) stock is retreating 4% today after the federal government announced a new probe of the firm. Additionally, Bank of America downgraded the shares to Neutral from Buy today.

Tesla (TSLA) stock headed higher on Wednesday ... said that this action was an "admission" that the SEC could not bring an "actual case". Bank of America (BAC) was the latest big bank to report results on Thursday, with its results pushing it slightly ...

Nvidia pushes back on new artificial-intelligence regulations, Tesla stock trades lower, Moderna issues weak revenue guidance, and Intra-Cellular Therapies is being acquired by Johnson & Johnson for nearly $15 billion.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Bank of ...